June 2017 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for June 2017. This roundup includes the latest...
ICD Treatment Cuts Sudden, All-Cause Death in Cardiomyopathy
Reduction in rate of all-cause, sudden mortality for adults with ischemic, nonischemic cardiomyopathy
EPO Doping Has Little Effect on Real-World Cycling Performance
Appears to improve high-intensity performance, not endurance or road race performance
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
Poll Finds Seniors Struggling With Drug Costs Don’t Seek Help
Roughly half of older Americans don't, but those who do receive assistance from their doctor
Robotic Navigation Noninferior for CVPI in Atrial Fibrillation
Longer procedure times with robotic ablation, but noninferior in terms of success, complications
Metformin Therapeutic As Post-Ischemic Conditioning Agent
Metformin maintains cell viability and membrane stability of cardiomyoblast cells from ischemic injury
ACA Health Insurance Expansion Tied to Fewer Cardiac Arrests
'Extraordinary reduction' seen among middle-aged adults after enactment of health care law
Review Links Flaxseed Consumption to Weight Reduction
Significant reduction in body weight, BMI, waist circumference following flaxseed consumption
Doctors Urged to Take Care With Electronic Communications
Sensitive information should be discussed in person or over the phone
